Mark K. Saville
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Ubiquitin and proteasome pathways 16
- Epigenetics and DNA Methylation 6
- Cancer-related gene regulation 4
- Genomics and Chromatin Dynamics 3
- Oncology 22
- Cancer-related Molecular Pathways 20
- Co-authors
- David P. Lane (11 shared papers)Dimitris P. Xirodimas (7 shared papers)Jean‐Christophe Bourdon (4 shared papers)Alison Sparks (8 shared papers)Nerea Allende-Vega (6 shared papers)Ronald T. Hay (2 shared papers)Kenneth Fernandes (4 shared papers)Alexandra Diot (1 shared paper)
- Journals
- Oncogene (10 papers)Journal of Biological Chemistry (4 papers)Biochemical Journal (2 papers)The EMBO Journal (2 papers)Oncotarget (2 papers)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Mark K. Saville
33 papers receiving 3.2k citations
Mark K. Saville's Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 1.9k
- Molecular Biology 2.7k
- Cancer Research 490
- Biotechnology 267
- Cell Biology 362
Countries citing papers authored by Mark K. Saville
This map shows the geographic impact of Mark K. Saville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Saville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Saville more than expected).
Fields of papers citing papers by Mark K. Saville
This network shows the impact of papers produced by Mark K. Saville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Saville. The network helps show where Mark K. Saville may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark K. Saville, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | p53 isoforms can regulate p53 transcriptional activity Hit paper breakdown → | 2005 | 631 |
| 2 | 2004 | 442 | |
| 3 | 2007 | 238 | |
| 4 | 2006 | 227 | |
| 5 | 2000 | 212 | |
| 6 | 2001 | 183 | |
| 7 | 2008 | 162 | |
| 8 | 2001 | 145 | |
| 9 | 2004 | 124 | |
| 10 | 2009 | 87 | |
| 11 | 2012 | 80 | |
| 12 | 2008 | 71 | |
| 13 | 1998 | 71 | |
| 14 | 2001 | 50 | |
| 15 | 2004 | 48 | |
| 16 | 2013 | 40 | |
| 17 | 2009 | 40 | |
| 18 | 1997 | 40 | |
| 19 | 2007 | 40 | |
| 20 | 1994 | 38 |
About Mark K. Saville
Mark K. Saville is a scholar working on Molecular Biology, Oncology, Cell Biology, Epidemiology and Cancer Research, having authored 33 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (20 papers), Ubiquitin and proteasome pathways (16 papers), Epigenetics and DNA Methylation (6 papers), Cancer-related gene regulation (4 papers), Genomics and Chromatin Dynamics (3 papers), Microtubule and mitosis dynamics (3 papers), Cancer Research and Treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Oncology (1.9k citations), Molecular Biology (2.7k citations), Cancer Research (490 citations), Biotechnology (267 citations) and Cell Biology (362 citations). Mark K. Saville has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include David P. Lane, Dimitris P. Xirodimas, Jean‐Christophe Bourdon, Alison Sparks, Nerea Allende-Vega, Ronald T. Hay, Kenneth Fernandes, Alexandra Diot, Geng Liu and Lauren Stevenson. Their work appears in journals such as Oncogene, Journal of Biological Chemistry, Biochemical Journal, The EMBO Journal and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.